| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.28 | 6e-06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.21 | 8e-06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.27 | 8e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |